A/Prof Klebe is a graduate of the Free University Berlin, who completed an MD in Germany, and postgraduate training in Pathology and a PhD at Flinders University in Adelaide, Australia. Her professional and academic interests over the last 16 years have concentrated upon asbestos-related disorders, especially lung cancer and malignant mesothelioma, including their diagnosis and pathogenesis.
She is the Director of Research of the Asbestos Disease Research Institute (ADRI), an Associate Professor at Flinders University and a Senior Consultant with SA Pathology. A/Prof Klebe is the current chair of the ICCR structured reporting committee for mesothelioma (2021), a member of the International Mesothelioma Panel, International Mesothelioma Interest Group and an author for the new WHO classification of lung and pleural tumours.
A/Prof Klebe had co-authored more than 80 peer-reviewed publications dealing with malignant mesothelioma and aspects of asbestos-related disease, in addition to chapters in textbooks, and many presentations at national and international conferences. She has supervised to completion PhD, honours and MD projects related to malignant mesothelioma, and I am currently leading a clinical trial.
A/Prof Klebe receives consult cases for all aspects of lung disease and has reviewed more than one thousand cases of mesothelioma, in addition to lung cancers, lung cancer precursor lesions and benign asbestos-related diseases of various types (pleural plaques, diffuse pleural fibrosis, benign asbestos pleuritis with effusion, rounded atelectasis, and asbestosis).
